Hbk Sorce Advisory LLC Grifols Sa Transaction History

Hbk Sorce Advisory LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$10.6 - $13.28 $26,828 - $33,611	2,531 Added 12.42%	22,915 $272,000
Q1 2022 May 13, 2022	BUY	$10.37 - $12.73 $23,093 - $28,349	2,227 Added 12.27%	20,384 $238,000
Q4 2021 Feb 15, 2022	BUY	$10.21 - $15.27 $185,382 - $277,257	18,157 New	18,157 $204,000
Q3 2021 Nov 15, 2021	SELL	$14.07 - $17.3 $193,912 - $238,428	-13,782 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$16.62 - $18.94 $30,414 - $34,660	1,830 Added 15.31%	13,782 $239,000
Q1 2021 May 14, 2021	BUY	$15.15 - $19.78 $28,072 - $36,652	1,853 Added 18.35%	11,952 $207,000
Q4 2020 Feb 12, 2021	BUY	$16.86 - $19.67 $170,269 - $198,647	10,099 New	10,099 $186,000

169

145M

166K

103K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.94B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.